Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011474 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Xavier Renaudin und 6 weiteren Autor:innen. Beteiligte Einrichtung: CNRS UMR9019, Université Paris-Saclay, Gustave Roussy Institute Cancer Campus, Villejuif, France. Hauptthemen laut MEDLINE: Fanconi Anemia, Cyclin-Dependent Kinase Inhibitor p21, Tumor Suppressor Protein p53, Reactive Oxygen Species. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer, Électricité de France, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Abnormal expression of the cell cycle inhibitor and p53 target CDKN1A /p21 has been associated with paradoxical outcomes, such as hyperproliferation in p53-deficient cancer cells or hypoproliferation that affects hematopoietic stem cell behavior, leading to bone marrow failure (BMF). Notably, p21 is known to be overexpressed in Fanconi anemia (FA), which is a rare syndrome that predisposes patients to BMF and cancer. However, why p21 is overexpressed in FA and how it contributes to the FA phenotype(s) are still poorly understood. Here, we revealed that while the upregulation of p21 is largely dependent on p53, it also depends on the transcription factor microphthalmia (MITF) as well as on its interaction with the nucleolar protein NPM1. Upregulation of p21 expression in FA cells leads to p21 accumulation in the chromatin fraction, p21 immunoprecipitation with PCNA, S-phase lengthening and genetic instability. p21 depletion in FA cells rescues the S-phase abnormalities and reduces their genetic instability. In addition, we observed that reactive oxygen species (ROS) accumulation, another key feature of FA cells, is required to trigger an increase in PCNA/chromatin-associated p21 and to impact replication progression. Therefore, we propose a mechanism by which p21 and ROS cooperate to induce replication abnormalities that fuel genetic instability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CNRS UMR9019, Université Paris-Saclay, Gustave Roussy Institute Cancer Campus, Villejuif, France.
- Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
ORCID-Profile: Xavier Renaudin
Förderung
- Ligue Contre le Cancer
- Électricité de France
- Agence Nationale de la Recherche
- Institut National Du Cancer
- Fondation pour la Recherche Médicale
- inserm school liliane bettencourt
Zitieren
APA
Renaudin, X., Al Ahmad Nachar, B., Mancini, B., Gueiderikh, A., Louis-Joseph, N., Maczkowiak-Chartois, F., & Rosselli, F. (2024). Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011474
Vancouver
Renaudin X, Al Ahmad Nachar B, Mancini B, Gueiderikh A, Louis-Joseph N, Maczkowiak-Chartois F, et al. Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011474
BibTeX
@article{Renaudin2024,
author = {Renaudin, Xavier and Al Ahmad Nachar, Baraah and Mancini, Benedetta and Gueiderikh, Anna and Louis-Joseph, Noémie and Maczkowiak-Chartois, Frédérique and Rosselli, Filippo},
title = {Contribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011474}
}
EUVIMED